LNC
40
-2
SJM
33
14
PGR
63
-4
CFG
60
-8
KO
42
-4
ACN
50
-6
SPG
56
-7
AMAT
48
6
LB
34
-15
KLAC
59
2
NI
70
-5
CTAS
56
-5
BIIB
43
11
ZTS
54
5
HES
63
-3
CME
62
-3
HCP
60
-2
NDAQ
57
-5
VLO
42
2
EL
37
7
LNC
40
-2
SJM
33
14
PGR
63
-4
CFG
60
-8
KO
42
-4
ACN
50
-6
SPG
56
-7
AMAT
48
6
LB
34
-15
KLAC
59
2
NI
70
-5
CTAS
56
-5
BIIB
43
11
ZTS
54
5
HES
63
-3
CME
62
-3
HCP
60
-2
NDAQ
57
-5
VLO
42
2
EL
37
7
Financhill
Back

BridgeBio Pharma Quote, Financials, Valuation and Earnings

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73

BBIO
BridgeBio Pharma

Last Price:
26.42
Seasonality Move:
-6.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

BridgeBio Pharma Price Quote

$26.42
-0.18 (-0.68%)
(Updated: December 3, 2024 at 2:20 PM ET)

BridgeBio Pharma Key Stats

Buy
73
BridgeBio Pharma (BBIO) is a Buy
Day range:
$26.15 - $27.17
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
22.27
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
2.2M
1-year change:
-14.03%
Market cap:
$5B
Revenue:
$9.3M
EPS:
$-2.41

How Much Does BridgeBio Pharma Make?

Is BridgeBio Pharma Growing As A Company?

  • What Is BridgeBio Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.33%
  • What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BridgeBio Pharma Stock Price Performance

  • Did BridgeBio Pharma Stock Go Up Last Month?
    BridgeBio Pharma share price went up by 4.4% last month
  • Did BBIO's Share Price Rise Over The Last Year?
    BBIO share price fell by -14.03% over the past 1 year

What Is BridgeBio Pharma 52-Week High & Low?

BridgeBio Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BridgeBio Pharma?

  • How Much Debt Does BridgeBio Pharma Have?
    Total long term debt quarterly is $1.7B
  • How Much Cash Does BridgeBio Pharma Have?
    Cash and short term investments quarterly total is $266.3M
  • What Is BridgeBio Pharma’s Book Value Per Share?
    Book value per share is -6.51

Is BridgeBio Pharma Cash Flow Positive?

  • What Is BBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$450.2M
  • What Is BridgeBio Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $270M
  • What Is BridgeBio Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $64M

BridgeBio Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    BBIO return on invested capital is -80.46%
  • What Is BridgeBio Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -62.51%
  • What Is BBIO Return On Equity?
    ROE is a measure of profitability and is 0%

BridgeBio Pharma Earnings Date & Stock Price

BridgeBio Pharma Competitors

  • Who Are BridgeBio Pharma's Competitors?
    Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Ionis Pharmaceuticals Inc (IONS)
    • Pfizer Inc (PFE)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Cassava Sciences Inc (SAVA)

BridgeBio Pharma Dividend Yield

BridgeBio Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.14%
Revenue: -33.22% -19.2%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 48.53
Upside from Last Price: 82.42%

Major Shareholders

  • How many BBIO shares are owned by institutional investors?
    242.3M BBIO shares are owned by institutional investors
  • How many BBIO shares are owned by insiders?
    7.3M BBIO shares are owned by insiders